0897.HK HKSE
Wai Yuen Tong Medicine Holdings Limited
1W: +1.4%
1M: +22.9%
3M: +38.9%
YTD: +1.4%
1Y: +15.4%
3Y: +33.7%
5Y: +108.1%
HK$0.38 ($0.05)
+0.01 (+1.35%)
Weekly Expected Move ±7.4%
HK$0
HK$0
HK$0
HK$0
HK$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#12
of 19
Drug Manufacturers - Specialty & Generic
Technical Signal Map
5 Bullish
0 Neutral
8 Bearish
0897.HK
$420M
Wai Yuen Tong Medicine Holdings Limited
BULLISH
+73
RGC
$3.1B
Regencell Bioscience Holdings Limited
BULLISH
+59
0013.HK
$20B
HUTCHMED (China) Limited
BULLISH
+53
0455.HK
$250M
Tianda Pharmaceuticals Limited
BULLISH
+43
0239.HK
$770M
Pak Fah Yeow International Limited
LEAN BULL
+26
3933.HK
$16B
The United Laboratories International Holdings Limited
LEAN BEAR
-24
0460.HK
$6.6B
Sihuan Pharmaceutical Holdings Group Ltd.
BEARISH
-49
0570.HK
$6.4B
China Traditional Chinese Medicine Holdings Co. Limited
BEARISH
-49
2348.HK
$1.5B
Dawnrays Pharmaceutical (Holdings) Limited
BEARISH
-58
2633.HK
$1.9B
Jacobson Pharma Corporation Limited
BEARISH
-66
3839.HK
$2.0B
CPBIO Holding Company Limited
BEARISH
-78
0867.HK
$26B
China Medical System Holdings Limited
BEARISH
-91
2161.HK
$1.3B
JBM (Healthcare) Limited
BEARISH
-91
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| 0897.HK Wai Yuen Tong Medicine Holdings Limited | $420M | 104.2 | -0.5 | -0.3 | -4.2 | -42.9 | 6 | BULLISH | 15.4 |
| RGC Regencell Bioscience Holdings Limited | $3.1B | -480.3 | -156.4 | 957.8 | — | 100.0 | 2 | BULLISH | -56.9 |
| 0013.HK HUTCHMED (China) Limited | $20B | 155.0 | 19.6 | 77.9 | 5.7 | -10.3 | 3 | BULLISH | -12.4 |
| 0455.HK Tianda Pharmaceuticals Limited | $250M | -6.9 | -16.3 | -11.4 | -19.7 | -17.2 | 2 | BULLISH | -34.1 |
| 0239.HK Pak Fah Yeow International Limited | $770M | 7.8 | 22.9 | 53.0 | 46.9 | -13.1 | 4 | LEAN BULL | 0.8 |
| 3933.HK The United Laboratories International Holdings Limited | $16B | 23.4 | 23.4 | 27.9 | 5.6 | -4.1 | 4 | LEAN BEAR | -50.5 |
| 0460.HK Sihuan Pharmaceutical Holdings Group Ltd. | $6.6B | 18.4 | 4.2 | -0.3 | 19.4 | 10.7 | 7 | BEARISH | -49.3 |
| 0570.HK China Traditional Chinese Medicine Holdings Co. Limited | $6.4B | -5.1 | -6.2 | -2.4 | -14.3 | -19.1 | 5 | BEARISH | -45.1 |
| 2348.HK Dawnrays Pharmaceutical (Holdings) Limited | $1.5B | 5.4 | 12.2 | 18.1 | 22.6 | -5.5 | 5 | BEARISH | -27.1 |
| 2633.HK Jacobson Pharma Corporation Limited | $1.9B | 6.4 | 24.6 | 21.2 | 18.5 | -7.5 | 7 | BEARISH | -31.9 |
| 3839.HK CPBIO Holding Company Limited | $2.0B | 10.5 | 10.0 | 8.1 | 3.4 | 73.6 | 8 | BEARISH | 19.0 |
| 0867.HK China Medical System Holdings Limited | $26B | 14.6 | 18.7 | 19.8 | 21.9 | 1.1 | 5 | BEARISH | -20.6 |
| 2161.HK JBM (Healthcare) Limited | $1.3B | 6.5 | 31.7 | 32.3 | 26.4 | 54.4 | 8 | BEARISH | -42.1 |
| 0897.HK Wai Yuen Tong Medicine Holdings Limited | $420M | 104.2 | -0.5 | -0.3 | -4.2 | -42.9 | 6 | BULLISH | 15.4 |
| RGC Regencell Bioscience Holdings Limited | $3.1B | -480.3 | -156.4 | 957.8 | — | 100.0 | 2 | BULLISH | -56.9 |
| 0013.HK HUTCHMED (China) Limited | $20B | 155.0 | 19.6 | 77.9 | 5.7 | -10.3 | 3 | BULLISH | -12.4 |
| 0455.HK Tianda Pharmaceuticals Limited | $250M | -6.9 | -16.3 | -11.4 | -19.7 | -17.2 | 2 | BULLISH | -34.1 |
| 0239.HK Pak Fah Yeow International Limited | $770M | 7.8 | 22.9 | 53.0 | 46.9 | -13.1 | 4 | LEAN BULL | 0.8 |
| 3933.HK The United Laboratories International Holdings Limited | $16B | 23.4 | 23.4 | 27.9 | 5.6 | -4.1 | 4 | LEAN BEAR | -50.5 |
| 0460.HK Sihuan Pharmaceutical Holdings Group Ltd. | $6.6B | 18.4 | 4.2 | -0.3 | 19.4 | 10.7 | 7 | BEARISH | -49.3 |
| 0570.HK China Traditional Chinese Medicine Holdings Co. Limited | $6.4B | -5.1 | -6.2 | -2.4 | -14.3 | -19.1 | 5 | BEARISH | -45.1 |
| 2348.HK Dawnrays Pharmaceutical (Holdings) Limited | $1.5B | 5.4 | 12.2 | 18.1 | 22.6 | -5.5 | 5 | BEARISH | -27.1 |
| 2633.HK Jacobson Pharma Corporation Limited | $1.9B | 6.4 | 24.6 | 21.2 | 18.5 | -7.5 | 7 | BEARISH | -31.9 |
| 3839.HK CPBIO Holding Company Limited | $2.0B | 10.5 | 10.0 | 8.1 | 3.4 | 73.6 | 8 | BEARISH | 19.0 |
| 0867.HK China Medical System Holdings Limited | $26B | 14.6 | 18.7 | 19.8 | 21.9 | 1.1 | 5 | BEARISH | -20.6 |
| 2161.HK JBM (Healthcare) Limited | $1.3B | 6.5 | 31.7 | 32.3 | 26.4 | 54.4 | 8 | BEARISH | -42.1 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
0897.HK vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F